Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients Autores: Ziv, E; Dean, E; Hu, DL; Martino, A; Serie, D; Curtin, K; Campa, D; Aftab, B; Bracci, P; Buda, G; Zhao, Y; Caswell-Jin, J; Diasio, R; Dumontet, C; Dudzinski, M; Fejerman, L; Greenberg, A; Huntsman, S; Jamroziak, K; Jurczyszyn, A; Kumar, S; Atanackovic, D; Glenn, M; Cannon-Albright, LA; Jones, B; Lee, A; Marques, H; Martin, T; Martinez-Lopez, J; Rajkumar, V; Sainz, J; Vangsted, AJ; Watek, M; Wolf, J; Slager, S; Camp, NJ; Canzian, F; Vachon, C A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia Autores: Garcia-Gutierrez, V; Gomez-Casares, MT; Puerta, JM; Alonso-Dominguez, JM; Osorio, S; Hernandez-Boiuda, JC; Collado, R; Ramirez, MJ; Ibanez, F; Martin, ML; Rodriguez-Gambarte, JD; Martinez-Laperche, C; Gomez, M; Fiallo, DV; Redondo, S; Rodriguez, A; Ruiz-Nuno, C; Steegmann, JL; Jimenez-Velasco, A Identification of miRSNPs associated with the risk of multiple myeloma Autores: Macauda, A; Calvetti, D; Maccari, G; Hemminki, K; Forsti, A; Goldschmidt, H; Weinhold, N; Houlston, R; Andersen, V; Vogel, U; Buda, G; Varkonyi, J; Sureda, A; Martinez Lopez, J; Watek, M; Butrym, A; Sarasquete, ME; Dudzinski, M; Jurczyszyn, A; Druzd-Sitek, A; Kruszewski, M; Subocz, E; Petrini, M; Iskierka-Jazdzewska, E; Razny, M; Szombath, G; Marques, H; Zawirska, D; Chraniuk, D; Halka, J; Jacobsen, SEH; Mazur, G; Sanz, RG; Dumontet, C; Moreno, V; Stepien, A; Beider, K; Pelosini, M; Reis, RM; Krawczyk-Kulis, M; Rymko, M; Avet-Loiseau, H; Lesueur, F; Grzasko, N; Ostrovsky, O; Jamroziak, K; Vangsted, AJ; Jerez, A; Tomczak, W; Zaucha, JM; Kadar, K; Sainz, J; Nagler, A; Landi, S; Gemignani, F; Canzian, F Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study Autores: Jurado, M; De La Mata, C; Ruiz-Garcia, A; Lopez-Fernandez, E; Espinosa, O; Remigia, MJ; Moratalla, L; Goterris, R; Garcia-Martin, P; Ruiz-Cabello, F; Garzon, S; Pascual, MJ; Espigado, I; Solano, C Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm Autores: Bernal, M; Jimenez, P; Puerta, J; Ruiz-Cabello, F; Jurado, M Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy Autores: Rios-Tamayo, R; Martin-Garcia, A; Alarcon-Payer, C; Sanchez-Rodriguez, D; de la Guardia, AMDVD; Collado, CGG; Morales, AJ; Chacon, MJ; Barrera, JC Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain Autores: Camara, R; Gozalbo, I; Jurado, M; Sanz, J; Aragon, B; Grau, S < 1 2 … 1.364 1.365 1.366 … 1.504 1.505 >